Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Summit Technology/Visx

This article was originally published in The Gray Sheet

Executive Summary

Summit Technology/Visx: Ophthalmic laser firms reach settlement of "all outstanding U.S. and international patent infringement disputes between them, including the infringement litigation in Delaware related to Summit's Azema patent and in Canada related to Visx's L'Esperance patents," the firms state. Under the terms of the agreement, the companies cross-license each other's foreign patents; in the U.S., Summit's Azema patent is contributed to Pillar Point Partners, a joint venture formed in 1992 to hold U.S. eye laser patents. An exchange of payments under the pact will result in a net $4.5 mil. payment to Summit...
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT008286

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel